We have had data....that is why they were especially selected for the international Phase 3 GBM trial.
How much data do you want ? - if indeed data drives price ....why are we at this cap ?
So indeed as you say, data will move the SP......what if the forthcoming data readouts are poor. We go lower if your thoughts are correct....much lower if all 3 readouts are poor.
So taking what you say about data moving the SP - poor future results and maybe a SP of 85cents - M/C of US$70 in that very high profile GBM trial. Does not make sense - but hey, as you say data moves the SP.
The issue here was those horrible capital raising and the way they promote - but more importantly looking to the future and the very real possibility of more poor decision making by management.
KZA Price at posting:
$1.31 Sentiment: Buy Disclosure: Held